scholarly article | Q13442814 |
P2093 | author name string | M. Hoffman | |
J. A. Oliver | |||
H. R. Roberts | |||
D. M. Monroe | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 170–177 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Thrombin activates factor XI on activated platelets in the absence of factor XII | |
P478 | volume | 19 |
Q36867848 | A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets |
Q45959804 | A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generation. |
Q88670342 | Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency |
Q33934481 | Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency |
Q35920828 | Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants |
Q37739907 | Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go? |
Q35649582 | Blood clot formation under flow: the importance of factor XI depends strongly on platelet count |
Q36619746 | Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow. |
Q64093592 | Coagulation Pathways in Neurological Diseases: Multiple Sclerosis |
Q92627046 | Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor |
Q36070475 | FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow |
Q37271059 | Factor XI contributes to thrombin generation in the absence of factor XII |
Q35921705 | Feedback activation of factor XI by thrombin does not occur in plasma |
Q34242634 | Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis? |
Q49273922 | Molecular genetic analysis of the F11 gene in 14 Turkish patients with factor XI deficiency: identification of novel and recurrent mutations and their inheritance within families |
Q38521771 | Platelet dysfunction in injured patients |
Q35631344 | Polyphosphate is a cofactor for the activation of factor XI by thrombin |
Q34294608 | Remodeling the blood coagulation cascade |
Q36271086 | Severe intraabdominal bleeding after transvaginal oocyte retrieval for IVF-ET and coagulation factor XI deficiency: a case report |
Q30476822 | Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively |
Q33717037 | Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood |
Q37853060 | The many faces of the contact pathway and their role in thrombosis |
Q36439538 | Thrombin activity propagates in space during blood coagulation as an excitation wave |
Q37770413 | Troubleshooting in platelet storage temperature and new perspectives through proteomics |
Q82103488 | [Thrombin generation in critical illnesses] |
Q50291193 | factor XI:platelet glycoprotein (GP) Ib:IX:V complex -> factor XIa:platelet glycoprotein (GP) Ib:IX:V complex (thrombin catalyst) |
Search more.